Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Cybin
Recent news which mentions Cybin
Cybin: Positive Data Announced From Innovative Drug Trial
March 02, 2023
Tags
Benzinga
Biotech
Market News
From
Benzinga
Cybin: Psychedelic Based BioPharma Company To Announce Much Anticipated Updates For Its Ongoing Clinical Trials
February 27, 2023
Tags
Interview
Benzinga
Biotech
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
CYB004
Markets
first/in/human dosing
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
Benzinga
Psychedelics
CYBN
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Psychedelics
Benzinga
Biotech
From
Benzinga
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
August 09, 2022
Tickers
CYBN
SEC
Tags
Cybin
News
Penny Stocks
From
Benzinga
How Does Ketamine Affect The Brain Over Time?
June 25, 2022
Tags
Kernel
Cannabis
Market News
From
Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Tickers
CYBN
Tags
Cybin
Psychedelics
Penny Stocks
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
Benzinga
Psychedelics
Biotech
From
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
Tickers
CYBN
Tags
Cybin
News
Benzinga
From
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Tickers
CYBN
Tags
CYBN
Markets
Cannabis
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
Doug Drysdale
Startups
CYBN
From
Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
Tickers
CYBN
Tags
CYBN
Kernel
Psychedelics
From
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Tickers
CYBN
Tags
Benzinga
Psychedelics
Penny Stocks
From
Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Tickers
CYBN
ENVB
FTRP
MNMD
Tags
ENVB
Cannabis
Market News
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Cybin
News
Benzinga
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Cannabis
Market News
Markets
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
CYBN
Small Cap
General
From
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
August 19, 2021
Tickers
CYBN
Tags
Market News
Global
Penny Stocks
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.